Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims

Riepilogo

The Food and Drug Administration (FDA) is announcing the availability of a guidance document entitled "Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims." This guidance outlines the agency's approach to the review of the scientific evidence for health claims that meet the significant scientific agreement standard (SSA) and qualified health claims. Elsewhere in this issue of the Federal Register, FDA is announcing the withdrawal of the guidance documents entitled "Guidance for Industry and FDA: Interim Evidence-Based Ranking System for Scientific Data" and "Guidance for Industry: Significant Scientific Agreement in the Review of Health Claims for Conventional Foods and Dietary Supplements."